We lead collaborative research projects designed to study safe and effective vaccines and treatments for infectious illnesses relevant to public health.

Through outreach, education, and partnerships, we strive to increase access to care and promote infectious-disease-related literacy and trust in clinical trials across New York City and beyond.

With world-class expertise and cutting-edge technologies, the Vaccine Center is uniquely positioned to respond rapidly to public health emergencies. During the COVID-19 pandemic in 2020 and the mpox outbreak in 2022 that hit New York City, we quickly launched critical clinical trials and research efforts to support timely, data-driven responses.

In recognition of our leadership in this space, the National Institute of Allergy and Infectious Diseases (NIAID) designated the Vaccine Center as a Vaccine and Treatment Evaluation Unit (VTEU) in 2020. We are proud to be part of the Infectious Diseases Clinical Research Consortium, a national network of 10 VTEU sites conducting pivotal clinical trials to advance public health.